ATA327685A - Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates - Google Patents

Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates

Info

Publication number
ATA327685A
ATA327685A AT0327685A AT327685A ATA327685A AT A327685 A ATA327685 A AT A327685A AT 0327685 A AT0327685 A AT 0327685A AT 327685 A AT327685 A AT 327685A AT A327685 A ATA327685 A AT A327685A
Authority
AT
Austria
Prior art keywords
producing
lymphokin
new
pharmaceutical preparation
pharmaceutical
Prior art date
Application number
AT0327685A
Other languages
English (en)
Other versions
AT395017B (de
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59236356A external-priority patent/JPH0811759B2/ja
Priority claimed from JP59236357A external-priority patent/JPS61115099A/ja
Priority claimed from JP60028396A external-priority patent/JPS61115026A/ja
Priority claimed from JP60166754A external-priority patent/JPS61115028A/ja
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of ATA327685A publication Critical patent/ATA327685A/de
Application granted granted Critical
Publication of AT395017B publication Critical patent/AT395017B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT0327685A 1984-11-09 1985-11-11 Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates AT395017B (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP59236356A JPH0811759B2 (ja) 1984-11-09 1984-11-09 新リンホカイン▲ｉｉ▼とその製法および用途
JP59236357A JPS61115099A (ja) 1984-11-09 1984-11-09 モノクロ−ナル抗体とその製法
JP60028396A JPS61115026A (ja) 1985-02-18 1985-02-18 新リンホカイン２の製造方法
JP60166754A JPS61115028A (ja) 1985-07-30 1985-07-30 抗腫瘍効果増強剤

Publications (2)

Publication Number Publication Date
ATA327685A true ATA327685A (de) 1992-01-15
AT395017B AT395017B (de) 1992-08-25

Family

ID=27458873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0327685A AT395017B (de) 1984-11-09 1985-11-11 Verfahren zur herstellung eines neuen lymphokins (lk 2) sowie verwendung von lk 2 zur herstellung eines pharmazeutischen praeparates

Country Status (11)

Country Link
US (4) US5019385A (de)
KR (1) KR930004596B1 (de)
AT (1) AT395017B (de)
AU (1) AU603053B2 (de)
CH (1) CH664574A5 (de)
DE (1) DE3539775C2 (de)
ES (2) ES8703161A1 (de)
FR (1) FR2572936B1 (de)
GB (1) GB2168355B (de)
IT (1) IT1184668B (de)
SE (1) SE468853B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
SK12942002A3 (sk) * 2000-02-10 2003-05-02 Abbott Laboratories Protilátky viažuce ľudský interleukín-18, spôsoby ich výroby a použitia
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US9107879B1 (en) * 2010-04-01 2015-08-18 Vanderbilt University Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and polyamine metabolism

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1164964A (en) * 1967-04-20 1969-09-24 Ceskoslovenska Akademie Ved A Method of Cultivation of Animal Cells, and Apparatus for Carrying Out the Said Method.
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5823847B2 (ja) * 1981-02-06 1983-05-18 株式会社 林原生物化学研究所 抗ヒト蛋白質抗体の製造方法
US4473493A (en) * 1981-04-29 1984-09-25 Immunex Corporation Hybridoma antibody which inhibits interleukin 2 activity
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
ATE37564T1 (de) * 1982-04-20 1988-10-15 Sloan Kettering Inst Cancer Reinigung von interleukin-2.
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
JPS5939832A (ja) * 1982-08-28 1984-03-05 Ajinomoto Co Inc モノクロ−ナル抗体ならびにその製法、使用法
EP0111344A2 (de) * 1982-12-13 1984-06-20 Sloan-Kettering Institute For Cancer Research Monoklonale Anti-Interleukin-2-Antikörper
DE3329449A1 (de) * 1983-08-16 1985-03-07 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Monoklonaler antikoerper, der eine struktur erkennt, die dem human-interleukin-2 (tcgf) und der leichten kette (lambda) von humanimmunglobulin gemeinsam ist, und hybridoma-zell-linien, die diese monoklonalen antikoerper produzieren
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
AU590543B2 (en) * 1985-02-05 1989-11-09 Albert Einstein College Of Medicine Of Yeshiva University Purification of native colony stimulating factor-1

Also Published As

Publication number Publication date
DE3539775A1 (de) 1986-11-06
US5002878A (en) 1991-03-26
DE3539775C2 (de) 1994-05-26
ES548727A0 (es) 1987-02-01
GB2168355A (en) 1986-06-18
ES8801582A1 (es) 1988-02-16
US5030564A (en) 1991-07-09
SE468853B (sv) 1993-03-29
IT8548762A0 (it) 1985-11-08
FR2572936B1 (fr) 1990-07-20
GB8527466D0 (en) 1985-12-11
US5003048A (en) 1991-03-26
AU4970885A (en) 1986-05-15
GB2168355B (en) 1989-04-19
AU603053B2 (en) 1990-11-08
CH664574A5 (fr) 1988-03-15
SE8505286L (sv) 1986-05-10
ES556785A0 (es) 1988-02-16
FR2572936A1 (fr) 1986-05-16
AT395017B (de) 1992-08-25
IT1184668B (it) 1987-10-28
US5019385A (en) 1991-05-28
KR930004596B1 (ko) 1993-06-01
ES8703161A1 (es) 1987-02-01
SE8505286D0 (sv) 1985-11-08
KR860006268A (ko) 1986-09-09

Similar Documents

Publication Publication Date Title
ATA245485A (de) Verfahren zur herstellung von neuen dihydropyridincarbonsaeure-derivaten
DE3769812D1 (de) Verwendung von phosphordiesteraseinhibitoren und cyclischen nukleotidanalogen zur herstellung eines arzneimittels zur stimulierung der traenensekretion.
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
ATA900385A (de) Verfahren zur herstellung einer pharmazeutischen zubereitung unter einsatz eines analgetischen und antiinflammatorischen nichtsteroiden wirkstoffes
AT389117B (de) Verfahren zur herstellung einer neuen, wasserfreien und stabilen deltakristallform von prazosinhydrochlorid
DE3667970D1 (de) Verfahren zur herstellung einer stabilen modifikation von torasemid sowie arzneimittel enthaltend torasemid.
AT386196B (de) Verfahren zur herstellung eines neuen indolderivates und seiner salze
ATA164187A (de) Verfahren zur herstellung eines pharmazeutischen pulvers
AT372390B (de) Verfahren zur herstellung von neuen 4'-jodderivaten von anthracyclinglykosiden
AT382156B (de) Verfahren zur herstellung von neuen cyclischen 9'-thiapeptidergotalkaloiden
ATA903983A (de) Verfahren zur herstellung einer analgetischen und antiinflammatorischen pharmazeutischen zubereitung
ATA254886A (de) Verfahren zur herstellung von neuen mitomycin-c-analogen
AT388670B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung mit einem gehalt an calciumantagonisten
ATA82386A (de) Verfahren zur herstellung von neuen 7beta-(2-(2amino-4-thiazolyl)-alkenoylamino)-3-cephem-4- carbonsaeureestern
ATA106786A (de) Verfahren zur herstellung der neuen 7-amino-3propenylcephalosporansaeure sowie von estern und salzen derselben
DE3581385D1 (de) Verfahren und verwendung eines isoliermittels zur trennung eines in einer kavitaet vorpolymerisierten composite-inlays.
AT383612B (de) Verfahren zur herstellung eines neuen antigenen proteins des maul- und klauenseuchevirus
DE59010245D1 (de) Strahlungsempfindliches Gemisch und Verfahren zur Herstellung von Reliefstrukturen
AT384226B (de) Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden
ATA133784A (de) Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten
AT376428B (de) Verfahren zur herstellung von neuen (3-alkylamino-2-hydroxypropoxy)-furan-2-carbons ureaniliden und deren physiologisch vertraeglichen saeureadditionssalzen
ATA143787A (de) Verfahren zur herstellung von neuen derivaten der 4-phenyl 4-oxo 2-butensaeure
DE59010681D1 (de) Strahlungsempfindliches Gemisch und Verfahren zur Herstellung von Reliefstrukturen
ATA326986A (de) Verfahren zur herstellung von neuen optisch aktiven 2-chlor-12-/3-dimethylamino-2-methylpropyl/-12h-dibenzo/d,g//1,3,6/dioxazocinen und saeureadditionssalzen derselben
ATA91186A (de) Verfahren zur herstellung von n-(1(s)|thoxycarbonyl-3-phenyl-propyl)-(s)-alanyl-(s)prolin und von dessen saeureadditionssalzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee